The California Division of Workers' Compensation's Pharmacy and Therapeutics Committee is scheduled to meet April 16.
Members of the committee that advises the division on evidence-based changes to the prescription drug formulary are scheduled to discuss biosimilar drugs, spending on topically applied drugs and cannabis coverage.
The meeting will also feature an update on the physician and pharmaceutical fee schedules and a public comment period.
The committee is meeting in person at the Elihu Harris state building in Oakland. The meeting will also be available by video and teleconf...
Comments